Status:

COMPLETED

Effect of Ketorolac and Remote Ischemic Preconditioning on Renal Ischemia-reperfusion Injury in Patients Undergoing Partial Nephrectomy

Lead Sponsor:

Yonsei University

Conditions:

Renal Cell Carcinoma

Eligibility:

All Genders

20-65 years

Phase:

NA

Brief Summary

Partial nephrectomy is a widely accepted alternative to radical nephrectomy in patients with clinically localized, unilateral renal cell carcinoma and a normal contralateral kidney. Interruption of re...

Eligibility Criteria

Inclusion

  • ASA l and ll
  • age 20-65
  • patients undergoing partial nephrectomy

Exclusion

  • preoperative liver or renal dysfunction,
  • coagulopathy,
  • chronic alcoholism,
  • hypersensitivity of NSAID,
  • history of warfarin,
  • history of gastric ulcer

Key Trial Info

Start Date :

December 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2013

Estimated Enrollment :

16 Patients enrolled

Trial Details

Trial ID

NCT01836406

Start Date

December 1 2012

End Date

June 1 2013

Last Update

February 19 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Severance hospital

Seoul, Seoul, South Korea, 120-752